Stanislaw Burzynski created and patented "Antineoplastons", successfully treating over a dozen forms of cancer with an Anti-neoplasm protocol. The FDA and Big PHARMA have attacked Dr. Burzynski and his treatment methodology, bringing him to court numerous times over the last decades. While the FDA criticized Dr. Burzynski's work, Big PHARMA recruited a physician associate of Dr. Burzynski and began research with Anti-neoplastons. Official clinical trials began without Dr. Burzynski. Although these trials cited the research of Dr. Burzynski they failed to follow his protocol. This failure resulted in an abrupt cancellation of the clinical trials as the patients being treated with Antineoplastons did not respond to treatment. (perhaps the proper protocol would have yielded positive results)



